logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Export All Citations
Copyright © Médecins Sans Frontières
v2.1.5758.produseast1
Showing 1 - 11 of 11 Items
Showing 1 - 11 of 11 Items
Citations
  • Download citations in various formats (CSV, BibTeX, EndNote) for use in reference managers and bibliographies.
  • Current Page (11)
  • CSV
  • BibTeX
  • EndNote
  • All Results (11)
  • CSV
  • BibTeX
  • EndNote
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries

Moon S, Jambert E, Childs M, von Schoen-Angerer T
2011-10-12 • Globalization and Health
2011-10-12 • Globalization and Health
BACKGROUND
Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widesprea...
Journal Article
|
Commentary
Journal Article
|
Commentary
Journal Article
|
Commentary

Expanding access to treatment for hepatitis C in resource-limited settings: Lessons from HIV/AIDS

Ford NP, Singh K, Cooke GS, Mills EJ, von Schoen-Angerer T,  et al.
2012-03-19 • Clinical Infectious Diseases
2012-03-19 • Clinical Infectious Diseases
Journal Article
|
Commentary
Journal Article
|
Letter
Journal Article
|
Commentary
Journal Article
|
Research
Journal Article
|
Letter
Journal Article
|
Commentary
Journal Article
|
Letter

Why it's time to say goodbye to Stavudine...everywhere

Andrieux-Meyer I, Clayden P, Collins S, Geffen N, Goemaere E,  et al.
2012-03-01 • Southern African Journal of HIV medicine
2012-03-01 • Southern African Journal of HIV medicine

Historic opportunity for WHO to re-assert leadership

Gillies R, von Schoen-Angerer T, 't Hoen E
2006-10-01 • Lancet
2006-10-01 • Lancet

Rational use of moxifloxacin for tuberculosis treatment

Cox HS, Ford NP, Keshavjee S, McDermid C, von Schoen-Angerer T,  et al.
2011-04-01 • Lancet Infectious Diseases
2011-04-01 • Lancet Infectious Diseases

Trading ideology for dialogue: an opportunity to fix international aid for health?

von Schoen-Angerer T
2003-07-12 • Lancet
2003-07-12 • Lancet

Focusing on quality patient care in the new global subsidy for malaria medicines

Moon S, Perez Casas C, Kindermans JM, de Smet M, von Schoen-Angerer T
2009-07-21 • PLOS Medicine
2009-07-21 • PLOS Medicine
Tido von Schoen-Angerer and colleagues discuss the new Affordable Medicines Facility for malaria (AMFm), which subsidizes and facilitates access to artemisinin-based combination therapy,...

How developing world concerns need to be part of drug development plans: A case study of four emerging antiretrovirals

van Roey J, von Schoen-Angerer T, Ford NP, Calmy A
2008-07-01 • Drug Discovery Today
2008-07-01 • Drug Discovery Today
Clinical trials are usually designed to meet registration requirements in developed countries, and do not always address key concerns for use in developing countries. Four late-stage inv...

Moxifloxacin for tuberculosis - Authors' reply

Cox HS, Ford NP, von Schoen-Angerer T
2012-03-01 • Lancet
2012-03-01 • Lancet

Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection

Maher D, von Schoen-Angerer T, Cohn J
2011-07-15 • International Journal of Clinical Practice
2011-07-15 • International Journal of Clinical Practice

UNITAID can address HCV/HIV co-infection

von Schoen-Angerer T, Cohn J, Piot P
2013-02-23 • Lancet
2013-02-23 • Lancet